ALTAREIT (EPA:AREIT) | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
ALTAREIT

BRIEF

published on 07/30/2024 at 17:50, 3 months 21 days ago

ALTAREIT: Availability of the half-yearly financial report as of June 30, 2024

Investors ALTAREIT AMF Financial Report 2024
BRIEF

published on 07/30/2024 at 17:50, 3 months 21 days ago

ALTAREIT: Availability of the Half-Year Financial Report

Half-year Report Financial Markets Authority ALTAREIT Financial Report 2024
REGULATED PRESS RELEASE

published on 07/30/2024 at 17:45, 3 months 21 days ago

ALTAREIT : Availability of the half-year financial report 30 June 2024
Altareit files half-year financial report for 2024 with French financial markets authority. Report accessible on company's website. Altareit, subsidiary of Altarea Group, specializes in property development in France

ALTAREIT French Financial Markets Authority France Property Development Half-year Financial Report
BRIEF

published on 07/05/2024 at 16:50, 4 months 15 days ago

ALTAREIT: Information on Voting Rights and Shares as of June 30, 2024

Share Capital Voting Rights ALTAREIT Actions Threshold Crossing
BRIEF

published on 07/05/2024 at 16:50, 4 months 15 days ago

ALTAREIT: Monthly Declaration of Securities Transactions for June 2024

Liquidity Euronext Paris ALTAREIT Corporate Actions June 2024
BRIEF

published on 07/05/2024 at 16:50, 4 months 15 days ago

Half-year review of Altareit's liquidity contract

Liquidity Contract Transactions ALTAREIT Kepler Cheuvreux AMF
BRIEF

published on 06/07/2024 at 19:05, 5 months 13 days ago

Altareit: Monthly declaration of transactions in its own securities - May 2024

Securities Liquidity Contract ALTAREIT Financial Operations Sotck Exchange
BRIEF

published on 06/07/2024 at 19:05, 5 months 13 days ago

ALTAREIT: Information on the number of voting rights and shares

Share Capital Voting Rights Actions Crossing Threshold Declaration Obligation
BRIEF

published on 06/07/2024 at 19:05, 5 months 13 days ago

ALTAREIT: New share buyback program approved by the general meeting

ALTAREIT Share Buyback AMF Buyback Program General Meeting 2024
BRIEF

published on 06/06/2024 at 17:29, 5 months 14 days ago

Altareit Combined General Meeting: Voting Results

ALTAREIT Resolutions General Assembly Auditors Remuneration

Accesswire

Published on 11/21/2024 at 13:30, 36 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 36 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 51 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 31 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 51 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 2 hours ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 2 hours 6 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 8 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 46 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 21 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 21 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE